Ameritas Investment Partners, Inc. Organon & Co. Transaction History
Ameritas Investment Partners, Inc.
- $2.8 Billion
- Q1 2025
A detailed history of Ameritas Investment Partners, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 1,000 shares of OGN stock, worth $8,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$8,430
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OGN
# of Institutions
808Shares Held
198MCall Options Held
1.84MPut Options Held
1.41M-
Black Rock Inc. New York, NY32.6MShares$275 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$250 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.7MShares$90.3 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$75.7 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.98MShares$67.3 Million0.29% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.14B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...